Oral Inqovi Safe and Effective Alternative MDS, CMML Treatment

Findings from the ASCERTAIN trial support the use of oral Inqovi for adults with intermediate- and high-risk myelodysplastic syndromes (MDS) such as chronic myelomonocytic leukemia (CMML).

Related Keywords

University Of Texas ,Texas ,United States ,Houston ,Guillermo Garcia Manero ,Inqovi Dacogen ,Drug Administration ,Taiho Oncology Inc ,Md Anderson Cancer Center ,Ora Inqovi ,Lancet Haematology ,Taiho Oncology ,Cancer Center ,Myelodysplastic Syndrome ,